---
title: 'Pan-TRK immunohistochemistry in gynaecological mesenchymal tumours: diagnostic
  implications and pitfalls'
date: '2023-11-21'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37988282/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20231122170715&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: 'CONCLUSION: Even though pan-TRK immunohistochemical expression is not
  entirely sensitive or specific for NTRK-rearranged sarcomas, these neoplasms tend
  to exhibit diffuse staining of moderate/strong intensity, unlike its mimics. Pan-TRK
  should be performed in monomorphic uterine (corpus and cervix) spindle cell neoplasms
  that are negative for smooth muscle markers and hormone receptors and positive for
  CD34 and/ or S100. Ultimately, the diagnosis requires molecular ...'
disable_comments: true
---
CONCLUSION: Even though pan-TRK immunohistochemical expression is not entirely sensitive or specific for NTRK-rearranged sarcomas, these neoplasms tend to exhibit diffuse staining of moderate/strong intensity, unlike its mimics. Pan-TRK should be performed in monomorphic uterine (corpus and cervix) spindle cell neoplasms that are negative for smooth muscle markers and hormone receptors and positive for CD34 and/ or S100. Ultimately, the diagnosis requires molecular ...